Association between Serum Biomarker Profile and Real-World Evidence of Disability in Multiple Sclerosis

被引:0
|
作者
Zhu, Wen [1 ]
Chen, Chenyi [1 ]
Zhang, Lili [1 ]
Walker, Elizabeth [1 ]
Venkatesh, Shruthi [1 ]
Zhang, Fujun [2 ]
Qureshi, Ferhan [2 ]
Hoyt, Tamara [3 ]
Foley, John [4 ]
Xia, Zongqi [1 ]
机构
[1] Univ Pittsburgh, Neurol, Pittsburgh, PA 15260 USA
[2] Octave Biosci Inc, Menlo Pk, CA USA
[3] Rocky Mt MS Res Grp, Salt Lake City, UT USA
[4] Rocky Mt MS Clin, Salt Lake City, UT USA
关键词
D O I
10.1212/WNL.0000000000203218
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S9.004
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Effectiveness and safety of dimethyl fumarate treatment in patients with relapsing multiple sclerosis: A real-world evidence
    Alroughani, Raed
    Ahmed, Samar
    Behbehani, Raed
    Al-hashel, Jasem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP17 - NP17
  • [32] Effectiveness and safety of dimethyl fumarate treatment in relapsing multiple sclerosis patients: Real-world evidence
    Alroughani R.
    Ahmed S.F.
    Behbehani R.
    Al-Hashel J.
    Neurology and Therapy, 2017, 6 (2) : 189 - 196
  • [33] Safety of high efficacy therapies in older people with Multiple Sclerosis: A real-world evidence study
    Silva, Berenice
    Casales, Federico
    Donoso, Claudia Burbano
    Varela, Lucia
    Heriz, Alejandra
    Gonzalez, Cecilia
    Miguez, Jimena
    Alonso, Ricardo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
  • [34] Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain
    Sempere, Angel P.
    Berenguer-Ruiz, Leticia
    Borrego-Soriano, Ines
    Burgos-San Jose, Amparo
    Concepcion-Aramendia, Luis
    Volar, Lucian
    Aragones, Miguel
    Palazon-Bru, Antonio
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [35] Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review
    Montalban, Xavier
    Matthews, Paul M.
    Simpson, Alex
    Petrie, John L.
    Sammon, Cormac
    Ramagopalan, Sreeram
    Disanto, Giulio
    Kuhle, Jens
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2023, 10 (03): : 302 - 311
  • [36] Real-world multiple sclerosis in Brazil: Patterns of natalizumab therapy
    Alves, Monique
    Carvalho, Fabricio
    Ferreira, Diana
    Rahal, Elaine
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 159 - 159
  • [37] Iron in multiple sclerosis - Neuropathology, immunology, and real-world considerations
    Zierfuss, Bettina
    Wang, Zitong
    Jackson, Alexandra N.
    Moezzi, Dorsa
    Yong, V. . Wee
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 78
  • [38] Real-world performance of alemtuzumab in multiple sclerosis patients in Chile
    Reyes, Ana
    Ciampi, Ethel
    Uribe San Martin, Reinaldo
    Carcamo, Claudia
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 142 - 143
  • [39] Real-World Effectiveness of Natalizumab in Korean Patients With Multiple Sclerosis
    Kim, Ki Hoon
    Kim, Su-Hyun
    Park, Na Young
    Hyun, Jae-Won
    Kim, Ho Jin
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [40] Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review
    John L. Petrie
    Charlie A. Smith
    Donna Fountain
    Gerardo Machnicki
    Neurology and Therapy, 2024, 13 (6) : 1597 - 1605